Director/PDMR Shareholding

RNS Number : 1559B
Venture Life Group PLC
14 June 2016
 

Venture Life Group PLC

 

("Venture Life" or the "Company")

 

Director/PDMR Shareholding

 

Bracknell, UK - 14 June 2016: Venture Life Group plc (AIM: VLG), the international consumer healthcare group addressing the self-care needs of the ageing population, announces that it was informed on 13 June 2016 that Ms. Sharon Collins, the Commercial Director of the Company, has undertaken dealings in 27,030 ordinary shares of 0.3p each in the Company ("Ordinary Shares"), transferring 26,430 of her current holding of Ordinary Shares to her ISA, and selling and re-purchasing 600 Ordinary Shares to be held in her non-ISA account.

 

The dealings were made between 8 June 2016 and 13 June 2016 as set out below:

 

Date

Dealing type

Number of Ordinary Shares sold

Number of Ordinary Shares purchased

Price (p)

8 June 2016

Sale

26,600

-

57.00

8 June 2016

Purchased to ISA

-

26,000

57.10

9 June 2016

Sale

430

-

57.00

9 June 2016

Purchased to ISA

-

430

57.00

Total sold

27,030

-

 

Total purchased to ISA

-

26,430

 

 

 

 

 

 

13 June 2016

Purchase

-

600

59.49

Total dealings

27,030

27,030

 

 

Following the dealings, Ms. Collins's beneficial interest in the Company remains unchanged at 1,582,417 Ordinary Shares, representing approximately 4.3% of the issued share capital in the Company.

 

 

For further information please contact:

Venture Life Group PLC

Jerry Randall, Chief Executive Officer                                                    +44 (0)1344 742 870

James Hunter, Chief Financial Officer                                                   

 

Panmure Gordon (UK) Limited (Nominated Adviser and Broker)                             
Freddy Crossley                                                                                                               +44 (0) 20 7886 2500

Peter Steel

Duncan Monteith                                                                                                           
Corporate Finance

Tom Salvesen
Corporate Broking                                                                                                          

 

Square1 Consulting

David Bick

Brian Alexander                                                                                                               +44 (0)20 7929 5599

 

 

 

 

About Venture Life

 

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product range and pipeline currently includes the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin.

The products, which typically are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.

 

Through its manufacturing company, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFLLRDISLIR
UK 100

Latest directors dealings